Nuffield Council Symposium Report: ‘Global health: responsibility, ethics and policy’

A report of the Nuffield Council on Bioethics’ 20th anniversary symposium ‘Global health: responsibility, ethics and policy’ has been published.
At the symposium, which took place on 22 June 2011, speakers from around the globe discussed topics such as ethics and responsibility in global health, non-communicable diseases, the role of emerging biotechnologies in global health, and social determinants of health.
Over 150 people attended the meeting, including clinicians, government officials, and representatives of research funding bodies, charities and pharmaceutical companies, both from the UK and abroad.
Albert Weale, Chair of the Council, summed up the day by highlighting some major themes that had emerged, including medical training and migration, interdependence, responsibility, and ‘health for all’ policies. The symposium will inform the Council as it considers its future work in the field of global health.

Download the report, a video showing highlights of the symposium, the programme, and speaker slides at:

Saved once (save)
Bookmarked by Dina Bogecho on 9 Feb 2012

Ethical issues of CRTs.

This site is primarily led by Charles Weijer at UWO.

Saved once (save)
Bookmarked by The Editorial Team on 14 Feb 2012
crt (1) ethics (1)

Ethics of clinical trials outsourcing and conduct in LMICs, with a focus on India.

Clinical trials in India continue to be in the news, unfortunately a fair bit being negative coverage. Over the last few years, there has been continuing outrage on the issue of rising outsourcing of clinical trials to India, with concerns about little benefit or relevance to the public health needs of the country. While this dust has not even settled, allegations of unethical conduct in clinical trials have again brought a focus on the need for regulatory reform and stringent ethical safeguards.

India, as an emerging economy needs to continue to promote a strong culture of research and development, including in the health sector. However, attention needs to be paid to ensuring that stringent quality checks are built in, and that investigators conduct research in an impeccable manner. Failure to do so will dent the credibility of the research enterprise, affecting not just investigators or institutions conducting research, but also those planning to do so.

Saved once (save)
Bookmarked by Anant Bhan on 10 May 2012

15th September 2023 • comment

This study highlights the utility of rapid ethical assessment prior to clinical trials involving complex procedures and concepts.

23rd March 2016 • comment

Community engagement is increasingly promoted to strengthen the ethics of medical research in low-income countries. One strategy is to use community advisory boards (CABs): semi-independent groups that can potentially safeguard the rights of study participants and help improve research. However, there is little published on the experience of operating and sustaining CABs.

12th March 2013 • comment
19th July 2012 • comment

Ethical tensions in dealing with noncommunicable diseases globally

by Sridhar Venkatapuram, Martin McKee, David Stuckler

“…..Noncommunicable diseases pose an increasingly high burden of disease that threatens economic and social development, yet cost-effective health interventions exist."

15th February 2012 • comment

The Draft Statement/Guidelines for Disaster Research

by Arthula Sumathipala, Aamir Jafarey, Leonardo de Castro, Aasim Ahmad, Darryl Marcer, Sandya Srinivasan, Nandini K. Kumar, Slemen Sutaryo, Anant Bhan, Dananyaja Wadeyaratne, Sriyakanthi Beneragama, Chandrani Jayasekera, Sarath Edirisingha, Chesmal Siriwardhana, Sisira Siribaddana

These guidelines were developed following a Working Group on Disaster Research and Ethics (WGDRE) meeting in 2007 with the aim of developing ethical guidelines which would be applicable to post-disaster research, partiuclarly that performed in the developing world. We welcome any feedback from members.

24th October 2011 • comment

Ethical issues in human genomics research in developing countries

by Jantina de Vries, Susan J Bull, Ogobara Doumbo, Muntaser Ibrahim, Odile Mercereau-Puijalon, Dominic Kwiatkowski, Michael Parker

Genome-wide association studies (GWAS) provide a powerful means of identifying genetic variants that play a role in common diseases. Such studies present important ethical challenges. An increasing number of GWAS are taking place in lower income countries and there is a pressing need to identify the particular ethical challenges arising in such contexts. In this paper, we draw upon the experiences of the MalariaGEN Consortium to identify specific ethical issues raised by such research in Africa, Asia and Oceania.

11th July 2011 • comment

This is a bibliography of articles on the topic of the theory and methodology of empirical ethics. This bibliography was last updated in June 2009, but is nonetheless included here as a potentially useful resource. We would like to keep this bibliography updated. Please let us know if we are missing any references - especially from the last two years.

8th March 2011 • comment

This article was written by a researcher from Sri Lanka and presents a very helpful overview on Biomedical Ethics. This article will be helpful to all levels of research staff and others who might want an accessible overview

26th October 2010 • comment

Clinical trial governance encompasses sponsorship, contracts, finance, confidentiality, trial insurance and professional indemnity and scientific and ethical review. You can find guidance and template documents relating to all of these topics throughout or you can contribute your own material to help others.

21st November 2009 • comment

The site initiation process is important as it ensures that all the logistics are organised and the site is ready to begin recruiting subjects.

21st November 2009 • comment

Clinical trial regulations can be confusing and unwieldy to researchers. The intention of this section is to explain what regulations exist, where they apply and how to work through them in a sensible and pragmatic way to determine what is applicable to any given trial.

21st November 2009 • comment